WASHINGTON D.C. – The Trump administration on Wednesday unveiled a significant initiative aimed at tackling the pervasive issue of microplastics and pharmaceutical contamination in the nation's drinking water. This new effort introduces stricter standards and expanded research, spearheaded by the Environmental Protection Agency (EPA) and Health and Human Services (HHS).
"For too long, Americans have raised concerns about plastics and pharmaceuticals in their drinking water. That ends today. By listing these substances for the first time, we commit to science-driven solutions and to protecting every American family." — Lee Zeldin, EPA Administrator
Central to this undertaking is the Systematic Targeting Of MicroPlastics (STOMP) program, which will be administered by the Advanced Research Projects Agency for Health (ARPA-H). The STOMP initiative is slated to receive $144 million in funding dedicated to studying the accumulation of microplastics within the human body and exploring effective, safe methods for their removal. Concurrently, the EPA and HHS have released the Sixth Contaminant Candidate List, formally identifying various chemicals and materials that may necessitate federal regulation under the Safe Drinking Water Act.
EPA Administrator Lee Zeldin emphasized the administration's commitment to addressing long-standing public concerns. "For too long, Americans have raised concerns about plastics and pharmaceuticals in their drinking water. That ends today," Zeldin stated. "By listing these substances for the first time, we commit to science-driven solutions and to protecting every American family."
Microplastics, defined as minute fragments derived from the degradation of larger plastic items and manufactured products like toothpaste and exfoliating scrubs, have become ubiquitous in the environment and human body. Studies indicate their presence throughout various human organs, including the lungs, brain, and digestive system. A 2019 study estimated that Americans ingest between 39,000 and 52,000 microplastic particles annually, a figure that can exceed 100,000 when inhalation is factored in. Research from the University of New Mexico, for instance, found microplastics in all 62 placentas analyzed, suggesting exposure can begin before birth.
HHS Secretary Robert F. Kennedy Jr. underscored the current gaps in scientific understanding regarding these contaminants. "We do not yet understand how microplastics interact with the immune system, endocrine system, or neurological processes, nor do we have validated methods for removal," Secretary Kennedy noted. The STOMP initiative is structured into two distinct phases: the first will investigate the mechanisms and extent of microplastic buildup in humans, while the second will concentrate on developing and validating safe strategies for their removal.
Beyond microplastics, pharmaceutical contaminants such as ibuprofen and acetaminophen are also under review. These substances frequently enter waterways through household disposal and are often not effectively filtered out by many existing water treatment plants. While scientific evidence remains preliminary, critics have pointed to potential risks to hormonal and reproductive systems associated with these contaminants.
The STOMP program operates within the broader framework of the "Make America Healthy Again" (MAHA) initiative, which aims to combat rising chronic disease rates across the nation. A 2025 MAHA report specifically highlighted concerning levels of microplastics found in children and pregnant women, underscoring the urgency for federal intervention.
Reactions from environmental advocates have been varied. Some have lauded the program as a long-overdue step towards ensuring cleaner drinking water. However, others expressed skepticism, viewing the announcement as largely symbolic. Suzanne Novak of Earthjustice characterized the initiative as a "PR stunt" that lacks enforceable standards and immediate protections for communities, according to NBC Chicago. Betsy Southerland, a former EPA Office of Water director, described the efforts as "early-stage research" that would require years to yield actionable outcomes.
Despite some reservations, experts generally stressed the importance of data collection and scientific inquiry. Rebecca Fry of UNC Chapel Hill expressed "cautious optimism," emphasizing that monitoring microplastics is crucial for understanding true exposure levels. Julian Fairey of the University of Arkansas pointed out that the inclusion of microplastics on the Contaminant Candidate List could unlock vital funding opportunities for future research. Currently, conclusive links between microplastics and specific diseases such as cancer, fertility disorders, or cardiovascular conditions have yet to be established.
The Trump administration has also opened a 60-day public comment period, inviting citizens to provide input that will help shape potential future regulations. Officials affirmed that public feedback would be integral in guiding decisions on how to manage these emerging drinking water contaminants.
